Develops microbiome-derived products using synthetic biology and explainable AI to prevent diseases and promote health in animals. By leveraging the animal's microbial ecosystem, it addresses unmet needs in animal health with tailored, science-based solutions.
Funding
$36.5M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
BMFounders
Product
Problem
Current animal health solutions often fail to fully address the complex interplay between an animal's microbiome and its overall well-being. This can lead to recurring disease, reduced productivity, and the overuse of antibiotics in animal agriculture. Existing interventions may lack the precision needed to target specific microbial imbalances, resulting in suboptimal health outcomes.
Solution
BiomEdit develops microbiome-derived products using synthetic biology and explainable AI to prevent diseases and promote health in animals. The company leverages an animal’s microbial ecosystem to create tailored, science-based solutions that address unmet needs in animal health. BiomEdit's technology platform utilizes high-throughput sequencing and data analytics to rapidly discover and screen novel probiotic species and bioactive molecules. These probiotics and microbially-derived compounds are engineered to enhance thermostability, increase the production of beneficial metabolites, or express immune-modulating proteins. This approach aims to promote animal health without relying on antibiotics.
Target Audience
BiomEdit's primary customers are animal agriculture producers, particularly those in the poultry industry, seeking innovative solutions to improve animal health, reduce reliance on antibiotics, and enhance productivity.
Features
- High-throughput sequencing for rapid microbiome analysis
- Explainable AI to identify key microbial targets
- Synthetic biology to engineer novel probiotics and bioactives
- Probiotic vectored antibody (pvAb™) technology for targeted disease control
- Engineered microbial medicines for enhanced efficacy and stability
- Products designed to combat necrotic enteritis in broiler chickens